BCTXZ
BriaCell Therapeutics Corp.
NASDAQ · Healthcare · Biotechnology · CA
$0.21
+31.76%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-127.4%
Return on equity
-113.2%
Return on assets
-133.0%
Return on invested capital
0.00x
Asset turnover
-$30.8M
Cash from operations
$12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Apr 1, 2026